Third Birmingham Gynaecological Cancer Workshop on Ovarian Cancer
Author Information
Author(s): R. Varma, G. Blackledge, G. Blackledge, C. Redman, J. Buxton
Primary Institution: Queen Elizabeth Hospital, Edgbaston, Birmingham
Hypothesis
What are we doing wrong with ovarian cancer management?
Conclusion
The workshop highlighted the need for further investigation into the management and treatment of ovarian cancer, particularly regarding its curability and the effectiveness of current therapies.
Supporting Evidence
- 80% of patients with stage I ovarian cancer have a 5-year survival with only surgical removal.
- Survival rates for patients managed conservatively were equivalent to those managed by conventional surgery.
- The introduction of cisplatin has significantly impacted survival in patients with advanced ovarian cancer.
Takeaway
Doctors are trying to figure out the best ways to treat ovarian cancer because many patients still don't get better, even with surgery and medicine.
Methodology
The workshop involved presentations and discussions among experts in the field regarding various aspects of ovarian cancer management.
Limitations
The ultimate impact of treatments on survival is still uncertain due to short follow-up periods in studies.
Want to read the original?
Access the complete publication on the publisher's website